肾脏疾病
腹膜透析
危险系数
肾脏替代疗法
急诊医学
肾病科
风险因素
人口
肾功能
优势比
作者
Bruce M. Robinson,Lin Tong,Jinyao Zhang,Robert A. Wolfe,David A. Goodkin,Roger Greenwood,Peter G. Kerr,Hal Morgenstern,Yun Li,Ronald L. Pisoni,Rajiv Saran,Francesca Tentori,Tadao Akizawa,Shunichi Fukuhara,Friedrich K. Port
摘要
KDOQI practice guidelines recommend predialysis blood pressure <140/90 mm Hg; however, most prior studies had found elevated mortality with low, not high, systolic blood pressure. This is possibly due to unmeasured confounders affecting systolic blood pressure and mortality. To lessen this bias, we analyzed 24,525 patients by Cox regression models adjusted for patient and facility characteristics. Compared with predialysis systolic blood pressure of 130-159 mm Hg, mortality was 13% higher in facilities with 20% more patients at systolic blood pressure of 110-129 mm Hg and 16% higher in facilities with 20% more patients at systolic blood pressure of ≥160 mm Hg. For patient-level systolic blood pressure, mortality was elevated at low (<130 mm Hg), not high (≥180 mm Hg), systolic blood pressure. For predialysis diastolic blood pressure, mortality was lowest at 60-99 mm Hg, a wide range implying less chance to improve outcomes. Higher mortality at systolic blood pressure of <130 mm Hg is consistent with prior studies and may be due to excessive blood pressure lowering during dialysis. The lowest risk facility systolic blood pressure of 130-159 mm Hg indicates this range may be optimal, but may have been influenced by unmeasured facility practices. While additional study is needed, our findings contrast with KDOQI blood pressure targets, and provide guidance on optimal blood pressure range in the absence of definitive clinical trial data.
科研通智能强力驱动
Strongly Powered by AbleSci AI